AR and prostate cancer: The CWR22Rv1 (22Rv1) cell line, another human prostate cancer cell line derived from xenografts of human metastatic prostate tumors, exhibits an intermediate profile with a mutated (overactive) AR and PSA expression (5), making it a unique tool for studying partial androgen signaling.